BRAF inhibitors have been occasionally linked to PRES—by increasing levels of cytokines, including tumor necrosis factor-α and interferon-γ, that increase vascular permeability and potentially lead to cerebral edema [66]. The gene discussed is TNF; the disease is Posterior Leukoencephalopathy Syndrome.